Brokerages expect MedEquities Realty Trust Inc (NYSE:MRT) to post $13.95 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for MedEquities Realty Trust’s earnings. The highest sales estimate is $14.35 million and the lowest is $13.19 million. MedEquities Realty Trust reported sales of $16.23 million in the same quarter last year, which would suggest a negative year-over-year growth rate of 14%. The firm is scheduled to announce its next earnings results on Wednesday, February 20th.
On average, analysts expect that MedEquities Realty Trust will report full year sales of $57.89 million for the current year, with estimates ranging from $57.15 million to $58.31 million. For the next year, analysts expect that the firm will report sales of $65.86 million, with estimates ranging from $62.16 million to $67.90 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that that provide coverage for MedEquities Realty Trust.
Get MedEquities Realty Trust alerts:Several equities research analysts have recently issued reports on MRT shares. JMP Securities set a $12.00 price objective on MedEquities Realty Trust and gave the stock a “buy” rating in a report on Tuesday, October 23rd. JPMorgan Chase & Co. upgraded MedEquities Realty Trust from an “underweight” rating to a “neutral” rating in a report on Wednesday, January 2nd. ValuEngine upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating in a report on Wednesday, January 2nd. Raymond James cut MedEquities Realty Trust to a “market perform” rating in a report on Friday, January 4th. Finally, Zacks Investment Research upgraded MedEquities Realty Trust from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 22nd. Ten analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. MedEquities Realty Trust has an average rating of “Hold” and an average price target of $10.89.
NYSE:MRT traded down $0.04 during trading hours on Friday, reaching $10.80. 274,108 shares of the company traded hands, compared to its average volume of 904,432. The stock has a market cap of $341.89 million, a PE ratio of 9.47 and a beta of 1.79. MedEquities Realty Trust has a 1-year low of $6.27 and a 1-year high of $11.85.
In related news, Director Bluemountain Capital Managemen sold 4,617 shares of the stock in a transaction on Thursday, December 6th. The stock was sold at an average price of $6.67, for a total value of $30,795.39. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders sold a total of 1,464,394 shares of company stock worth $15,566,349 over the last ninety days. Corporate insiders own 3.00% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of MRT. Prudential Financial Inc. raised its position in shares of MedEquities Realty Trust by 41.0% in the 4th quarter. Prudential Financial Inc. now owns 2,603,235 shares of the financial services provider’s stock worth $17,806,000 after buying an additional 756,318 shares during the period. BlackRock Inc. raised its position in shares of MedEquities Realty Trust by 14.8% in the 3rd quarter. BlackRock Inc. now owns 1,721,509 shares of the financial services provider’s stock worth $16,733,000 after buying an additional 222,015 shares during the period. Vanguard Group Inc raised its position in shares of MedEquities Realty Trust by 7.0% in the 3rd quarter. Vanguard Group Inc now owns 3,151,744 shares of the financial services provider’s stock worth $30,635,000 after buying an additional 205,635 shares during the period. Vanguard Group Inc. raised its position in shares of MedEquities Realty Trust by 7.0% in the 3rd quarter. Vanguard Group Inc. now owns 3,151,744 shares of the financial services provider’s stock worth $30,635,000 after buying an additional 205,635 shares during the period. Finally, Renaissance Technologies LLC raised its position in shares of MedEquities Realty Trust by 21.5% in the 3rd quarter. Renaissance Technologies LLC now owns 1,020,302 shares of the financial services provider’s stock worth $9,917,000 after buying an additional 180,502 shares during the period. 91.77% of the stock is currently owned by institutional investors and hedge funds.
About MedEquities Realty Trust
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
Featured Story: Net Margin
Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment